The hybridoma technique for producing monoclonal antibodies Revision Notes | GCSE AQA Higher Biology
Monoclonal antibodies are made by fusing lymphocytes from a mouse's spleen with tumour cells to form hybridoma cells. Free notes and 13 questions answered.
Updated 20 Mar 2026 · Revise Right Team
The hybridoma technique for producing monoclonal antibodies is part of Monoclonal antibodies (biology only) (HT only) in GCSE AQA Higher Biology.
3 min
Reading time
17
Lessons in this topic
GCSE AQA Higher
Pathway
Reviewed by Revise Right
Content review
What this lesson covers
Monoclonal antibodies are made by fusing lymphocytes from a mouse's spleen with tumour cells to form hybridoma cells. Free notes and 13 questions answered.
Explain how hybridoma cells are created by combining lymphocytes with tumour cells
Describe the process of producing monoclonal antibodies using the hybridoma technique
Evaluate the advantages of using hybridoma cells for antibody production
Apply knowledge of cell division and antibody production to explain industrial applications
Revise Right Mocks '26
AQA GCSE Biology mock draft, 26–31 Oct. Draft coverage: Biology Paper 1 (Higher tier). Reviewed for an original-practice sitting; check student availability before registering. Marking and results will follow later, after separate approval. Eligible new accounts receive a five-day Pro trial when signup email verification completes. Previous trials keep their original expiry. After expiry, new papers need Pro unless you have an explicitly confirmed free sitting offer for this event. That offer adds no Pro time or AI learning. Saved attempts and released results remain readable. No card or automatic charge.
Use this lesson to stay inside Monoclonal antibodies (biology only) (HT only) while connecting the detail back to the wider Infection and response topic.
Infection and response
Monoclonal antibodies (biology only) (HT only)
GCSE AQA Higher Biology
Revision notes
Read the core explanations from The hybridoma technique for producing monoclonal antibodies before testing yourself from memory.
1. The Problem with Natural Antibody Production
Your immune system makes brilliant antibodies that target specific diseases. But there's a catch - the cells that make them don't live very long, and they produce many different types mixed together.
Imagine trying to collect pure gold from a mine where the gold-producing machines keep breaking down and also produce silver, copper, and tin at the same time. That's the challenge scientists faced when they wanted large amounts of identical antibodies for medical treatments.
Trap: Many students think lymphocytes live forever and keep making antibodies. Actually, they die quite quickly - that's why we need memory cells for long-term immunity.
2. The Hybridoma Solution
Scientists found a clever solution: combine the best of both worlds. Take a lymphocyte (makes specific antibodies) and fuse it with a tumour cell (divides forever). The result? A hybridoma cell that makes identical antibodies and never stops dividing.
Think of it like creating a factory that produces exactly the product you want (specific antibodies) and never shuts down (immortal like tumour cells). This solves both problems at once.
3. The Step-by-Step Hybridoma Technique
The hybridoma technique follows a precise sequence. Each step is crucial for success, and missing any step means the whole process fails.
Worked example: Creating Hybridoma Cells for Monoclonal Antibody Production
Produce large amounts of identical antibodies against a specific antigen using the hybridoma technique.
Inject mouse with specific antigen → lymphocytes produce antibodies against that antigen — This 'trains' the lymphocytes to make the exact antibody we want
Remove lymphocytes from mouse spleen (where they concentrate) — Spleen contains the highest concentration of antibody-producing cells
Mix lymphocytes with immortal tumour cells → cell fusion creates hybridomas — Tumour cells provide the 'immortality' - ability to divide forever
Test which fused cells produce the desired antibody AND can divide — Many fusions fail - only successful hybridomas have both abilities
Isolate individual hybridoma cells → grow identical copies (clones) — Each clone produces exactly the same antibody - that's why they're 'monoclonal'
Collect antibodies from cloned cells → purify to remove other substances — Final product: large amounts of identical, pure antibodies
Answer: Large quantities of identical monoclonal antibodies ready for medical or research use
4. Why This Technique Works So Well
The hybridoma technique is brilliant because it solves multiple problems simultaneously. Let's break down exactly why each component is essential.
The lymphocyte contributes: Specific antibody production against the target antigen. Without this, we'd have no antibodies at all.
The tumour cell contributes: Immortality - the ability to divide forever without dying. Without this, production would stop when the lymphocytes die.
The cloning step ensures: All antibodies are identical. Without this, we'd still have a mixture of different antibodies.
5. Applications and Advantages
Monoclonal antibodies produced by hybridomas have revolutionised medicine and research. They're used in pregnancy tests, cancer treatments, and COVID-19 rapid tests.
The key advantages over natural antibody production are consistency, purity, and scale. Every antibody molecule is identical, there are no unwanted antibodies mixed in, and you can produce tonnes of them.
A practical limitation is that only hybridoma clones producing the exact target antibody can be scaled up. Scientists must screen many clones, then select and culture the best one to maintain specificity and reliability.
6. Exam Technique and Common Mistakes
Exam questions on hybridomas often test the sequence of steps and the reasons why each step is necessary. Here's how to tackle them successfully.
Common mistake: Students often forget to explain WHY each step is necessary. Don't just describe WHAT happens - explain WHY it's needed for the process to work.
Remember: the hybridoma technique is essentially biological engineering - combining the best features of two different cell types to create something neither could achieve alone.
Sources and content standards
Published by Revise Right. Use the official specification reference to check the requirements for your course. Content updated: 2026-03-20.
Monoclonal antibodies are made by injecting a mouse with a specific antigen, removing the stimulated lymphocytes from its spleen and fusing them with tumour cells to form hybridoma cells. Successful hybridomas are selected, single cells are cloned, and the identical antibodies are collected from the cloned cells for medical or research use.
What are monoclonal antibodies used for?
Monoclonal antibodies produced by hybridomas are used in pregnancy tests, cancer treatments and COVID-19 rapid tests. Their advantages over natural antibody production are consistency, purity and scale: every antibody is identical, no unwanted antibodies are mixed in, and tonnes can be produced.
What is a hybridoma cell?
A hybridoma cell is a cell created by fusing a lymphocyte with a tumour cell, combining antibody production with unlimited cell division. The lymphocyte provides specific antibody production and the tumour cell provides immortality, the ability to divide forever.
What is screening in the hybridoma technique?
Screening is the process of testing many hybridoma clones to identify the clone that produces the required monoclonal antibody with the correct specificity. Only that clone is selected and cultured on a large scale, because many fusions fail.
Why are lymphocytes fused with tumour cells?
Lymphocytes are fused with tumour cells because lymphocytes make specific antibodies but have a limited lifespan, while tumour cells divide forever but do not make antibodies. The fused hybridoma cell makes identical antibodies and never stops dividing, solving both problems at once.
Why are they called monoclonal antibodies?
They are called monoclonal antibodies because they are produced by clones of a single hybridoma cell. Individual hybridoma cells are isolated and grown into identical copies, so each clone produces exactly the same antibody, all targeting the same specific antigen.
What is the hybridoma technique?
The hybridoma technique is the process of making monoclonal antibodies by fusing stimulated mouse lymphocytes with tumour cells to create hybridoma cells. These are cloned so that each clone produces large amounts of identical antibodies against one specific antigen.
Why are lymphocytes taken from the spleen?
Lymphocytes are taken from the mouse spleen because the spleen contains the highest concentration of antibody-producing cells. After the mouse is injected with the antigen, these lymphocytes produce antibodies against that antigen.
Why are hybridoma cells cloned?
Hybridoma cells are cloned so that all the antibodies produced are identical. Individual hybridoma cells are isolated and grown into identical copies, and each clone produces exactly the same antibody, which is why they are called monoclonal.
Do lymphocytes live forever?
Lymphocytes do not live forever; they die quite quickly, which is why memory cells are needed for long-term immunity. For antibody production, lymphocytes are fused with tumour cells, which can divide forever.
What does each cell contribute to a hybridoma?
In a hybridoma, the lymphocyte contributes specific antibody production against the target antigen, and the tumour cell contributes immortality, the ability to divide forever. Cloning then ensures all the antibodies are identical rather than a mixture.
What are the advantages of producing antibodies with hybridomas?
The advantages of producing antibodies with hybridomas are consistency, purity and scale: every antibody molecule is identical, no unwanted antibodies are mixed in, and tonnes can be produced. Natural antibody production gives a short-lived mixture of different antibodies.
What is the last step in making monoclonal antibodies?
The last step in making monoclonal antibodies is to harvest the antibodies from the cloned hybridoma cells and purify them to remove other substances. The final product is large amounts of identical, pure antibodies ready for medical or research use.